DTC genetic testing International Team Debuts New Platform for DIY Genetic Analysis and Interpretation Premium Called Personal Access to Genome and Analysis of Natural Traits, or PAGEANT, the platform enables users to analyze and interpret their genomic data at no cost. 23andMe Gains Foothold in Primary Care, Disease Prevention With Lemonaid Health Acquisition Premium The consumer genetic testing giant sees the $400 million deal as a catalyst for personalized healthcare. 23andMe to Acquire Telemedicine Platform Company Lemonaid Health for $400M in Cash, Stock Lemonaid Health, based in San Francisco, offers a platform that provides online access to a variety of telemedicine and pharmacy services. Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test The firm's health screening sequencing assay, which retails at $249 and covers a panel of over 400 genes, will now be available to consumers in all 50 states. Sequencing Firm Phosphorus Tests Limits of Comprehensive Consumer Genomics With GeneCompass Premium The company is providing its 400-gene test through a physician-involved DTC model akin to Color and Invitae, but with content across a much larger swath of disease and health. Jul 26, 2021 Canine Genetics Firm Embark Veterinary Raises $75M in Series B Round Jul 19, 2021 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA for $4M Jan 21, 2021 Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics Premium Jan 7, 2021 Consumer DNA Testing Firm MyDNA Merges With Gene by Gene Dec 29, 2020 23andMe Raises $82.5M in Private Financing Dec 10, 2020 Following Acquisition, UK Firm MyHealthChecked Launches SARS-CoV-2 Consumer Testing Service Premium Aug 4, 2020 Fulgent Genetics Revenues More Than Double in Q2, Driven by COVID-19 Testing Aug 3, 2020 Ancestry Rolls Out Sequencing-Based Health Offering Focused on Common Conditions Premium May 29, 2020 BTIG Initiates Coverage of Fulgent Genetics May 26, 2020 NantOmics Shuts Down Genos Direct-to-Consumer Genomics Services May 4, 2020 Fulgent Genetics Q1 Revenues Jump 44 Percent Apr 24, 2020 Ancestry to Make Consumer Genomics Database Available for COVID-19 Research Project Mar 6, 2020 As Consumer Genomics Market Cools, Providers Ponder Better Ways to Reach Customers Premium Feb 14, 2020 Amid Customer Complaints, Genetic Testing Firm Pathway OME Acquired by OME Wellness Premium Feb 6, 2020 Dante Labs Taps BC Platforms for Informatics Support as NGS Testing Ramps Up Premium Jan 15, 2020 Veritas Genetics Restarts US Business With Near-Term Financing Jan 6, 2020 LifeVault's GoodCell Looks to Expand Personal Biobanking Business, Touts Cell Quality Monitoring Premium Dec 17, 2019 Direct-to-Consumer Biobanking Firm LifeVault Bio Raises $5.6M Dec 5, 2019 Veritas Genetics Halts US Operations, Lays Off More Than 30 Nov 25, 2019 Stratify Genomics Taps PWNHealth to Offer Prostate Cancer Risk Test Online Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Polarized Science Confidence A new survey finds that confidence in science among US adults is increasingly polarized, the Associated Press says. Time to Sit Back and Relax NPR reports that the US National Institutes of Health has transferred the last of its eligible former research chimpanzees to a sanctuary. Omicron-Focused Vaccines The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant. Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more.